Gilead Sciences, Inc. GILD Archived

-0.77%
Discovered (Elapsed 195days) Discovery price $136.30 Current price $135.25 Price updated

This entry is more than 3 months old and has been archived. Prices reflect the last update.

✅ Key Summary

Gilead Sciences, Inc. focuses on antiviral drugs, particularly for HIV and hepatitis. The company reported solid earnings driven by its key products, but faces challenges from generic competition. The stock is currently trading at $136.30, reflecting a significant premium based on its valuation metrics.

Advertisement

🏢 Company Overview

Gilead Sciences, Inc. is a biopharmaceutical company that develops and commercializes innovative medicines. The company has a strong portfolio of antiviral drugs, particularly for HIV, hepatitis B, hepatitis C, and influenza. Recently, Gilead reported strong earnings, driven primarily by sales of its HIV therapies. However, it is facing increasing competition from generic alternatives, which may impact future revenue growth. The stock's current price of $136.30 indicates a substantial premium, as reflected in its calculated basis point of 85847. Investors should consider the potential for market volatility as Gilead navigates these challenges. Overall, the company maintains a solid position in the industry with ongoing research and development efforts.

📰 Related News

  • Gilead Reports Q1 Earnings Beat
    Positive earnings surprise boosts investor confidence.
  • Generic Competition Intensifies in Hepatitis C Market
    Potential revenue pressure from increased generic offerings.
  • FDA Approves New HIV Treatment
    Expansion of product portfolio may enhance market position.

🏭 Competitor Comparison

  • AbbVie Inc. ABBV
    Focuses on immunology and oncology, providing diversification away from antivirals.
  • Bristol Myers Squibb Company BMY
    Offers a broad range of therapies, including oncology and cardiovascular drugs.
  • Merck & Co., Inc. MRK
    Competes in vaccines and infectious disease treatments, differing from Gilead's antiviral focus.

📅 Gilead Sciences, Inc. discovery history

This stock has been discovered 6 times.

DiscoveredDiscovery priceCurrent priceReturn
Sep 17, 2026 $150.89 $168.08 +11.39%
Aug 12, 2026 $135.87 $170.87 +25.76%
Apr 1, 2026 $140.30 $126.34 -9.95%
Jan 30, 2026 $141.95 $130.84 -7.83%
Dec 24, 2025 $125.67 $138.11 +9.90%
Go to the Gilead Sciences, Inc. ticker page →
Advertisement

Other recent discoveries

← Back to list